These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17018760)

  • 1. Non-small cell lung cancer: second-line and beyond.
    Stahel RA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x97-100. PubMed ID: 17018760
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bevacizumab with platinum chemotherapy as 6th-line treatment in a case of non-small-cell lung cancer].
    Ishiura Y; Yamamoto H; Terasaki Y; Ishida Y; Tohge M; Segawa M; Kusajima Y; Saitoh K; Ishikawa M; Hirokami N; Kasahara K; Fujimura M
    Gan To Kagaku Ryoho; 2011 Dec; 38(13):2631-3. PubMed ID: 22189231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemotherapy in non-small-cell lung carcinoma. More than just promises?].
    Feliu J; Ordóñez A; Espinosa J
    Med Clin (Barc); 1994 Jun; 103(2):72-5. PubMed ID: 8051975
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy in stage III non-small cell lung cancer.
    Eberhardt WE; Hepp R
    Eur J Cancer; 2009 Sep; 45 Suppl 1():126-36. PubMed ID: 19775611
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic chemotherapy in advanced non-small cell lung cancer.
    Scagliotti GV; Novello S; Selvaggi G
    Monaldi Arch Chest Dis; 2005 Dec; 63(4):181-3. PubMed ID: 16454216
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.
    Hensing TA; Schell MJ; Lee JH; Socinski MA
    Lung Cancer; 2005 Feb; 47(2):253-9. PubMed ID: 15639724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemetrexed plus bevacizumab for second-line therapy of non-small-cell lung cancer: the importance of patient selection.
    Araujo AM
    J Clin Oncol; 2010 Mar; 28(8):e131; author reply e132. PubMed ID: 20100954
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of non-small-cell lung carcinoma: PS2 patients' particularities].
    Deppermann KM
    Rev Pneumol Clin; 2004 Nov; 60(5 Pt 3):4S31-4S34. PubMed ID: 15687991
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic treatment of non-small-cell lung cancer.
    Lal R; Enting D; Kristeleit H
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S375-7. PubMed ID: 21944021
    [No Abstract]   [Full Text] [Related]  

  • 10. [Controversies in the treatment of non-small cell lung cancer; adjuvant chemotherapy].
    Dediu M
    Pneumologia; 2001; 50(2):115-7. PubMed ID: 11584671
    [No Abstract]   [Full Text] [Related]  

  • 11. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
    Greillier L; Barlesi F
    Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of chemotherapy in non-small cell lung carcinoma].
    Giaccone G; Dingemans AM
    Ned Tijdschr Geneeskd; 1996 May; 140(21):1111-4. PubMed ID: 8692336
    [No Abstract]   [Full Text] [Related]  

  • 13. [New trends in adjuvant chemotherapy for non-small-cell lung cancer].
    Dediu M; Alexandru A; Median D; Vremeş G
    Pneumologia; 2005; 54(2):89-93. PubMed ID: 16536008
    [No Abstract]   [Full Text] [Related]  

  • 14. Who are less likely to receive subsequent chemotherapy beyond first-line therapy for advanced non-small cell lung cancer? Implications for selection of patients for maintenance therapy.
    Sun JM; Park JO; Won YW; Kim JH; Yun J; Lee J; Park YH; Ahn JS; Ahn MJ; Park K
    J Thorac Oncol; 2010 Apr; 5(4):540-5. PubMed ID: 20195170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials referral resource. Clinical trials in non-small-cell lung cancer.
    Saxman SB; Blatner GL; Cheson BD
    Oncology (Williston Park); 1999 Oct; 13(10):1384, 1387-8. PubMed ID: 10549565
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung.
    Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J
    N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691
    [No Abstract]   [Full Text] [Related]  

  • 17. Elderly patients with advanced non-small-cell lung cancer.
    Belani CP
    Clin Lung Cancer; 2003 Sep; 5(2):76. PubMed ID: 14596687
    [No Abstract]   [Full Text] [Related]  

  • 18. [Paclitaxel-bevacizumab is a possible alternative as salvage chemotherapy in advanced non-small cell bronchial carcinoma].
    Zarza V; Couraud S; Bosc C; Toffart AC; Moro-Sibilot D; Souquet PJ
    Rev Mal Respir; 2014 Sep; 31(7):601-7. PubMed ID: 25239581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process.
    De Pas T; de Braud F; Veronesi G
    J Thorac Oncol; 2010 May; 5(5):754. PubMed ID: 20421773
    [No Abstract]   [Full Text] [Related]  

  • 20. [Role of chemotherapy in the treatment of advanced stage non-small-cell bronchial cancer].
    Sculier JP
    Rev Mal Respir; 1993; 10(4):287-9. PubMed ID: 8235020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.